University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Sample size considerations for trials using cerebral white matter hyperintensity progression as an intermediate outcome at 1 year after mild stroke: results of a prospective cohort study

dc.contributor.authorChappell, Francesca M.
dc.contributor.authorValdes Hernandez, Maria del Carmen
dc.contributor.authorMakin, Stephen D.
dc.contributor.authorShuler, Kirsten
dc.contributor.authorSakka, Eleni
dc.contributor.authorDennis, Martin S.
dc.contributor.authorArmitage, Paul A.
dc.contributor.authorMunoz Maniega, Susana
dc.contributor.authorWardlaw, Joanna M.
dc.contributor.institutionUniversity of Aberdeen.Other Applied Health Sciencesen
dc.date.accessioned2020-06-05T13:25:01Z
dc.date.available2020-06-05T13:25:01Z
dc.date.issued2017-02-21
dc.descriptionWe thank the staff of the Brain Research Imaging Centre (http://www.sbirc.ed.ac.uk/) and Neuroimaging Sciences (http://www.ed.ac.uk/clinical-brain-sciences/research/research-methodologies/neuroimaging), University of Edinburgh, but mostly all the participants and relatives who took part in the study. This work was funded by the Wellcome Trust (grant 088134/Z/09/A), Row Fogo Charitable Trust, Age UK, Scottish Funding Council and the Chief Scientist Office of Scotland for the Scottish Imaging Network: A Platform for Scientific Excellence (“SINAPSE”) and the Brain Research Imaging Centre.en
dc.description.statusPeer revieweden
dc.format.extent10
dc.format.extent494053
dc.identifier147310966
dc.identifier27392afd-e568-4b21-962c-f1389c152ab2
dc.identifier85014350854
dc.identifier.citationChappell, F M, Valdes Hernandez, M D C, Makin, S D, Shuler, K, Sakka, E, Dennis, M S, Armitage, P A, Munoz Maniega, S & Wardlaw, J M 2017, 'Sample size considerations for trials using cerebral white matter hyperintensity progression as an intermediate outcome at 1 year after mild stroke: results of a prospective cohort study', Trials, vol. 18, 78. https://doi.org/10.1186/s13063-017-1825-7en
dc.identifier.doi10.1186/s13063-017-1825-7
dc.identifier.issn1745-6215
dc.identifier.otherRIS: urn:92DBF99EAA9664CCE487C080D7A8C27F
dc.identifier.otherRIS: 10873
dc.identifier.otherORCID: /0000-0001-8701-9043/work/76976283
dc.identifier.urihttps://hdl.handle.net/2164/14452
dc.identifier.urlhttps://pubmed.ncbi.nlm.nih.gov/28222778/en
dc.identifier.vol18en
dc.language.isoeng
dc.relation.ispartofTrialsen
dc.subjectWhite matter hyperintensitiesen
dc.subjectSample size calculationen
dc.subjectStudy designen
dc.subjectR Medicineen
dc.subjectWellcome Trusten
dc.subject088134/Z/09/Aen
dc.subjectScottish Funding Councilen
dc.subjectScottish Imaging Networken
dc.subjectSINAPSEen
dc.subject.lccRen
dc.titleSample size considerations for trials using cerebral white matter hyperintensity progression as an intermediate outcome at 1 year after mild stroke: results of a prospective cohort studyen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Chappel_et_al_BMCTrials_Sample_size_considerations_VOR.pdf
Size:
482.47 KB
Format:
Adobe Portable Document Format

Collections